BALCX
Price
$38.57
Change
-$0.01 (-0.03%)
Updated
Oct 14 closing price
Net Assets
265.09B
ETNMX
Price
$15.01
Change
+$0.07 (+0.47%)
Updated
Oct 14 closing price
Net Assets
390.72M
Interact to see
Advertisement

BALCX vs ETNMX

Header iconBALCX vs ETNMX Comparison
Open Charts BALCX vs ETNMXBanner chart's image
American Funds American Balanced C
Price$38.57
Change-$0.01 (-0.03%)
VolumeN/A
Net Assets265.09B
Eventide Balanced Fund
Price$15.01
Change+$0.07 (+0.47%)
VolumeN/A
Net Assets390.72M
BALCX vs ETNMX Comparison Chart in %
View a ticker or compare two or three
VS
BALCX vs. ETNMX commentary
Oct 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BALCX is a Hold and ETNMX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BALCX has more cash in the bank: 265B vs. ETNMX (391M). ETNMX pays higher dividends than BALCX: ETNMX (1.83) vs BALCX (1.12). BALCX was incepted earlier than ETNMX: BALCX (25 years) vs ETNMX (10 years). BALCX (1.31) is less costly to investors than ETNMX (1.09). ETNMX is a more actively managed with annual turnover of: 55.00 vs. BALCX (44.00). BALCX has a lower initial minimum investment than ETNMX: BALCX (250) vs ETNMX (1000). BALCX annual gain was more profitable for investors over the last year : 7.34 vs. ETNMX (3.08). BALCX return over 5 years is better than : 37.49 vs. ETNMX (29.06).
BALCXETNMXBALCX / ETNMX
Total Expense Ratio1.311.02128%
Annual Report Gross Expense Ratio1.311.09120%
Fund Existence25 years10 years-
Gain YTD13.6886.837200%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets265B391M67,775%
Annual Yield % from dividends1.121.8361%
Returns for 1 year7.343.08238%
Returns for 3 years50.1737.81133%
Returns for 5 years37.4929.06129%
Returns for 10 years67.1886.7077%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JFNNX74.040.29
+0.39%
Janus Henderson Global Life Sciences N
HNDDX78.73N/A
N/A
Horizon Equity Premium Income Investor
NFEAX18.56N/A
N/A
Columbia Large Cap Growth Opp A
MSECX11.21N/A
N/A
Morgan Stanley Inst International Eq C
CLBCX38.87-0.01
-0.03%
American Funds American Balanced 529C